Nanjing Vishee Medical Technology Co., Ltd. (688580) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Nanjing Vishee Medical Technology Co., Ltd.

Why is Nanjing Vishee Medical Technology Co., Ltd. ?

Poor Management Efficiency with a low ROCE of 65.26%

The company has been able to generate a Return on Capital Employed (avg) of 65.26% signifying low profitability per unit of total capital (equity and debt)

The company is Net-Debt Free

Poor long term growth as Net Sales has grown by an annual rate of 3.42% and Operating profit at -4.37% over the last 5 years
The company is Net-Debt Free
The company has been able to generate a Return on Equity (avg) of 8.58% signifying low profitability per unit of shareholders funds

Poor long term growth as Net Sales has grown by an annual rate of 3.42% and Operating profit at -4.37% over the last 5 years

The company has declared Positive results for the last 3 consecutive quarters

OPERATING CASH FLOW(Y) Highest at CNY 182.99 MM
NET PROFIT(HY) At CNY 100.12 MM has Grown at 44.43%
ROCE(HY) Highest at 10.2%

With ROE of 9.24%, it has a fair valuation with a 2.94 Price to Book Value

Over the past year, while the stock has generated a return of -11.06%, its profits have risen by 45.6% ; the PEG ratio of the company is 0.7
At the current price, the company has a high dividend yield of 0.5

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Nanjing Vishee Medical Technology Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Nanjing Vishee Medical Technology Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Nanjing Vishee Medical Technology Co., Ltd.

-10.8%

1.04

55.79%

China Shanghai Composite

3.23%

0.23

14.72%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

3.42%

EBIT Growth (5y)

-4.37%

EBIT to Interest (avg)

86.26

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.62

Sales to Capital Employed (avg)

0.26

Tax Ratio

11.36%

Dividend Payout Ratio

75.00%

Pledged Shares

Institutional Holding

ROCE (avg)

24.73%

ROE (avg)

8.58%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.94

EV to EBIT

36.40

EV to EBITDA

30.76

EV to Capital Employed

5.13

EV to Sales

8.95

PEG Ratio

0.70

Dividend Yield

0.52%

ROCE (Latest)

14.10%

ROE (Latest)

9.24%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

16What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 182.99 MM

NET PROFIT(HY)

At CNY 100.12 MM has Grown at 44.43%

ROCE(HY)

Highest at 10.2%

INVENTORY TURNOVER RATIO(HY)

Highest at 4.32 times

INTEREST COVERAGE RATIO(Q)

The company hardly has any interest cost

RAW MATERIAL COST(Y)

Fallen by -0.86% (YoY

OPERATING PROFIT(Q)

Highest at CNY 43.05 MM

-2What is not working for the Company

CASH AND EQV(HY)

Lowest at CNY 1,790.9 MM

DEBT-EQUITY RATIO (HY)

Highest at -50.81 %

Here's what is working for Nanjing Vishee Medical Technology Co., Ltd.

Operating Cash Flow

Highest at CNY 182.99 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Profit

At CNY 100.12 MM has Grown at 44.43%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Inventory Turnover Ratio

Highest at 4.32 times and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Operating Profit

Highest at CNY 43.05 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (CNY MM)

Raw Material Cost

Fallen by -0.86% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Nanjing Vishee Medical Technology Co., Ltd.

Cash and Eqv

Lowest at CNY 1,790.9 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio

Highest at -50.81 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio